The search for markers of glycocalyx damage that can predict S-AKI is ongoing
How They Differ The differences are entirely in dosage, FDA approval, and marketing : Ozempic (Diabetes Medication) FDA-Approved Use: Treatment of Type 2 Diabetes Mellitus Reducing cardiovascular risk in diabetic patients Dosing Schedule: Starting dose: 0.25 mg weekly (first 4 weeks) Maintenance dose: 0.5 mg or 1.0 mg weekly Maximum dose: 2.0 mg weekly Intended Primary Effect: Blood sugar control A1C reduction Weight Loss Status: Acknowledged as a side effect Not the primary indication Insurance may not cover for weight loss alone Off-Label Use Reality: Many doctors prescribed Ozempic specifically for weight loss before Wegovy became available
Northwestern University Gastroparesis Support Group Northwestern University offers a gastroparesis support group, hosted by the Digestive Health Centers Behavioral Medicine Program
Hypoglycemia Despite having a pronounced anti-hyperglycemic effect, GLP-1 RAs are not typically associated with hypoglycemia when used as monotherapy
With several coronavirus vaccine candidates advancing to the third and final phase of clinical trials, researchers are ramping up their efforts to ensure that older adults are well represented among the tens of thousands of volunteers rolling up their sleeves to test the various vaccines
Research published in Clinical Immunology explored this further
